Current Stem Cell Research & Therapy

Author(s): Wen Yang and Bo Ma*

DOI: 10.2174/1574888X13666180912141228

A Mini-Review: The Therapeutic Potential of Bone Marrow Mesenchymal Stem Cells and Relevant Signaling Cascades

Page: [214 - 218] Pages: 5

  • * (Excluding Mailing and Handling)

Abstract

Bone marrow mesenchymal stem cells (BMSCs) characterized multi-directional differentiation, low immunogenicity and high portability, serve as ideal “seed cells” in ophthalmological disease therapy. Therefore, in this mini-review, we examined the recent literature concerning the potential application of BMSCs for the treatment of ophthalmological disease, that includes: the cellular activity of BMSCs transplantation, migration and homing, as well as the immuno-modulatory and antiinflammatory effects of BMSCs and signaling involved. Each aspect is complementary to the others and together these aspects promoted further understanding of the potential use of BMSCs in treating ophthalmological diseases.

Keywords: BMSCs, signaling, ophthalmological, bone marrow, mesenchymal stem cells, embryogenesis.

[1]
Shamsul BS, Tan KK, Chen HC, Aminuddin BS, Ruszymah BH. Posterolateral spinal fusion with ostegenesis induced BMSC seeded TCP/HA in a sheep model. Tissue Cell 2014; 46(2): 152-8.
[2]
Xu J, Liu X, Chen J, et al. Cell-cell interaction promotes rat marrow stromal cell differentiation into endothelial cell via activation of TACE/TNF-alpha signaling. Cell Transplant 2010; 19(1): 43-53.
[3]
Xu XL, Tang T, Dai K, et al. Immune response and effect of adenovirus-mediated human BMP-2 gene transfer on the repair of segmental tibial bone defects in goats. Acta Orthop 2005; 76(5): 637-46.
[4]
Lee RH, Kim B, Choi I, et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004; 14(4-6): 311-24.
[5]
Beloti MM, Rosa AL. Osteoblast differentiation of human bone marrow cells under continuous and discontinuous treatment with dexamethasone. Braz Dent J 2005; 16(2): 156-61.
[6]
Hughes FJ, McCulloch CA. Stimulation of the differentiation of osteogenic rat bone marrow stromal cells by osteoblast cultures. Lab Invest 1991; 64(5): 617-22.
[7]
Qi Y, Du Y, Li W, et al. Cartilage repair using mesenchymal stem cell (MSC) sheet and MSCs-loaded bilayer PLGA scaffold in a rabbit model. Knee Surg Sports Traumatol Arthrosc 2014; 22(6): 1424-33.
[8]
Alfaro MP, Vincent A, Saraswati S, et al. sFRP2 suppression of bone morphogenic protein (BMP) and Wnt signaling mediates mesenchymal stem cell (MSC) self-renewal promoting engraftment and myocardial repair. J Biol Chem 2010; 285(46): 35645-53.
[9]
Zhu X, Liu Y, Yin Y, et al. MSC p43 required for axonal development in motor neurons. Proc Natl Acad Sci USA 2009; 106(37): 15944-9.
[10]
Holmes D. Diabetes: MSC transplant prevents beta-cell dysfunction. Nat Rev Endocrinol 2014; 10(12): 701.
[11]
Hu Y, Xiong LL, Zhang P, Wang TH. Microarray expression profiles of genes in lung tissues of rats subjected to focal cerebral ischemia-induced lung injury following bone marrow-derived mesenchymal stem cell transplantation. Int J Mol Med 2017; 39(1): 57-70.
[12]
Raza K, Larsen T, Samaratunga N, et al. MSC therapy attenuates obliterative bronchiolitis after murine bone marrow transplant. PLoS One 2014; 9(10): e109034.
[13]
Tai WL, Dong ZX, Zhang DD, Wang DH. Therapeutic effect of intravenous bone marrow-derived mesenchymal stem cell transplantation on early-stage LPS-induced acute lung injury in mice. Nan Fang Yi Ke Da Xue Xue Bao 2012; 32(3): 283-90.
[14]
Tang N, Zhao Y, Feng R, et al. Lysophosphatidic acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibroblasts. J Cell Mol Med 2014; 18(1): 156-69.
[15]
Wu Q, Wang F, Hou Y, et al. The effect of allogenetic bone marrow-derived mesenchymal stem cell transplantation on lung aquaporin-1 and -5 in a rat model of severe acute pancreatitis. Hepatogastroenterology 2012; 59(116): 965-76.
[16]
Xie X. Liu H1, Wu J, Rat BMSC infusion was unable to ameliorate inflammatory injuries in tissues of mice with LPS-induced endotoxemia. Biomed Mater Eng 2017; 28(s1): S129-38.
[17]
Xu MH, Gao X, Luo D, Zhou XD, Xiong W, Liu GX. EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells. PLoS One 2014; 9(2): e87893.
[18]
Zhu F. Guo GH1, Chen W1, Wang NY. Effects of bone marrow-derived mesenchymal stem cells engraftment on vascular endothelial cell growth factor in lung tissue and plasma at early stage of smoke inhalation injury. World J Emerg Med 2010; 1(3): 224-8.
[19]
Cancedda R, Mastrogiacomo M, Bianchi G, Derubeis A, Muraglia A, Quarto R. Bone marrow stromal cells and their use in regenerating bone. Novartis Found Symp 2003. 249: 133-43; discussion 143-7, 170-4, 239-41.
[20]
Park J, Gelse K, Frank S, von der Mark K, Aigner T, Schneider H. Transgene-activated mesenchymal cells for articular cartilage repair: a comparison of primary bone marrow-, perichondrium/periosteum- and fat-derived cells. J Gene Med 2006; 8(1): 112-25.
[21]
Mareddy S, Crawford R, Brooke G, Xiao Y. Clonal isolation and characterization of bone marrow stromal cells from patients with osteoarthritis. Tissue Eng 2007; 13(4): 819-29.
[22]
Auletta JJ, Deans RJ, Bartholomew AM. Emerging roles for multipotent, bone marrow-derived stromal cells in host defense. Blood 2012; 119(8): 1801-9.
[23]
Wakitani S, Okabe T, Horibe S, et al. Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. J Tissue Eng Regen Med 2011; 5(2): 146-50.
[24]
Yamasaki S, Mera H, Itokazu M, Hashimoto Y, Wakitani S. Cartilage repair with autologous bone marrow mesenchymal stem cell transplantation: Review of preclinical and clinical studies. Cartilage 2014; 5(4): 196-202.
[25]
Yang D, Sun S, Wang Z, Zhu P, Yang Z, Zhang B. Stromal cell-derived factor-1 receptor CXCR4-overexpressing bone marrow mesenchymal stem cells accelerate wound healing by migrating into skin injury areas. Cell Reprogram 2013; 15(3): 206-15.
[26]
Meng H, Wang Z, Wang W, et al. Effect of osteopontin in regulating bone marrow mesenchymal stem cell treatment of skin wounds in diabetic mice. Diabetes Metab Res Rev 2014; 30(6): 457-66.
[27]
Wu Y, Huang S, Enhe J, et al. Bone marrow-derived mesenchymal stem cell attenuates skin fibrosis development in mice. Int Wound J 2014; 11(6): 701-10.
[28]
Kuo KC, Lin RZ, Tien HW, et al. Bioengineering vascularized tissue constructs using an injectable cell-laden enzymatically crosslinked collagen hydrogel derived from dermal extracellular matrix. Acta Biomater 2015; 27: 151-66.
[29]
Periasamy R, Surbek DV, Schoeberlein A. In vitro-microenvironment directs preconditioning of human chorion derived MSC promoting differentiation of OPC-like cells. Tissue Cell 2018; 52: 65-70.
[30]
Wu GH, Shi HJ, Che MT, et al. Recovery of paralyzed limb motor function in canine with complete spinal cord injury following implantation of MSC-derived neural network tissue. Biomaterials 2018; 181: 15-34.
[31]
Liu S, Wang X, Xiao Z, Tang A, Tang W, Shen S. [Effect of Feridex-GFP double-labeled BMSC transplant on the damaged liver under the condition of constant magnetic field]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2014; 39(10): 1008-15.
[32]
Millward DJ. Michael John Rennie, MSc, PhD, FRSE, FHEA, 1946-2017: an appreciation of his work on protein metabolism in human muscle. Am J Clin Nutr 2017; 106(1): 1-9.
[33]
Bornes TD, Jomha NM, Mulet-Sierra A, Adesida AB. Porous scaffold seeding and chondrogenic differentiation of bmsc-seeded scaffolds. Bio Protoc 2015; 5(24)
[34]
Jiang Z, Wang H, Yu K, et al. Light-controlled bmsc sheet-implant complexes with improved osteogenesis via an LRP5/beta-Catenin/Runx2 regulatory loop. ACS Appl Mater Interfaces 2017; 9(40): 34674-86.
[35]
Zhao R, Li Y, Lin Z, et al. miR-199b-5p modulates BMSC osteogenesis via suppressing GSK-3beta/beta-catenin signaling pathway. Biochem Biophys Res Commun 2016; 477(4): 749-54.
[36]
Redondo J, Sarkar P, Kemp K, et al. Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro. Mult Scler 2018; 24(7): 919-31.
[37]
Long H, Sun B, Cheng L, et al. miR-139-5p Represses BMSC osteogenesis via targeting Wnt/beta-Catenin signaling pathway. DNA Cell Biol 2017; 36(8): 715-24.
[38]
Zhang GW, Gu TX, Guan XY, et al. HGF and IGF-1 promote protective effects of allogeneic BMSC transplantation in rabbit model of acute myocardial infarction. Cell Prolif 2015; 48(6): 661-70.
[39]
Wang S, Tong M, Hu S, Chen X, et al. The bioactive substance secreted by MSC retards mouse aortic vascular smooth muscle cells calcification. BioMed Res Int 2018; 2018: 6053567.
[40]
Vafaei R, Nassiri SM, Siavashi V. beta3-Adrenergic regulation of epc features through manipulation of the bone marrow MSC niche. J Cell Biochem 2017; 118(12): 4753-61.
[41]
Bunpetch V, Zhang ZY, Zhang X, et al. Strategies for MSC expansion and MSC-based microtissue for bone regeneration. Biomaterials 2019; 196: 67-79.
[42]
Chang PY, Zhang BY, Cui S, et al. MSC-derived cytokines repair radiation-induced intra-villi microvascular injury. Oncotarget 2017; 8(50): 87821-36.
[43]
Dong H, Li G, Shang C, et al. Umbilical cord mesenchymal stem cell (UC-MSC) transplantations for cerebral palsy. Am J Transl Res 2018; 10(3): 901-6.
[44]
Zhang X, Sun Y, Liu J, et al. In situ forming hydrogels with long-lasting miR-21 enhances the therapeutic potential of MSC by sustaining stimulation of target gene. J Biomater Sci Polym Ed 2017; 28(15): 1639-50.
[45]
de Witte SFH, Merino AM, Franquesa M, et al. Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease. Stem Cell Res Ther 2017; 8(1): 140.
[46]
Zhang S, Chuah SJ, Lai RC, Hui JHP, Lim SK, Toh WS. MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity. Biomaterials 2018; 156: 16-27.
[47]
Tang Q. Luo C1, Lu B, Thermosensitive chitosan-based hydrogels releasing stromal cell derived factor-1 alpha recruit MSC for corneal epithelium regeneration. Acta Biomater 2017; 61: 101-13.
[48]
Zhang LX, Shen LL, Ge SH, et al. Systemic BMSC homing in the regeneration of pulp-like tissue and the enhancing effect of stromal cell-derived factor-1 on BMSC homing. Int J Clin Exp Pathol 2015; 8(9): 10261-71.
[49]
Sato K, Mera H, Wakitani S, Takagi M. Effect of epigallocatechin-3-gallate on the increase in type II collagen accumulation in cartilage-like MSC sheets. Biosci Biotechnol Biochem 2017; 81(6): 1241-5.
[50]
Popa MA, Mihai MC, Constantin A, et al. Dihydrotestosterone induces pro-angiogenic factors and assists homing of MSC into the cardiac tissue. J Mol Endocrinol 2018; 60(1): 1-15.
[51]
José VSS, Monnerat G, Guerra B, et al. Bone-marrow-derived mesenchymal stromal cells (MSC) from diabetic and nondiabetic rats have similar therapeutic potentials. Arq Bras Cardiol 2017; 109(6): 579-89.
[52]
Long Q, Upadhya D, Hattiangady B, et al. Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus. Proc Natl Acad Sci USA 2017; 114(17): E3536-45.
[53]
Caires HR, Barros da Silva P, Barbosa MA, Almeida CR. A co-culture system with three different primary human cell populations reveals that biomaterials and MSC modulate macrophage-driven fibroblast recruitment. J Tissue Eng Regen Med 2018; 12(3): e1433-40.
[54]
Kim WS, Kim HJ, Lee ZH, Lee Y, Kim HH. Apolipoprotein E inhibits osteoclast differentiation via regulation of c-Fos, NFATc1 and NF-kappaB. Exp Cell Res 2013; 319(4): 436-46.
[55]
Kim S, Han YS, Lee JH, Lee SH. Combination of MSC spheroids wrapped within autologous composite sheet dually protects against immune rejection and enhances stem cell transplantation efficacy. Tissue Cell 2018; 53: 93-103.
[56]
Deng L, Hu G, Jin L, Wang C, Niu H. Involvement of microRNA-23b in TNF-alpha-reduced BMSC osteogenic differentiation via targeting runx2. J Bone Miner Metab 2018; 36(6): 648-60.
[57]
Esteves CL, Sheldrake TA, Mesquita SP, et al. Isolation and characterization of equine native MSC populations. Stem Cell Res Ther 2017; 8(1): 80.
[58]
Schubert S, Brehm W, Hillmann A, Burk J. Serum-free human MSC medium supports consistency in human but not in equine adipose-derived multipotent mesenchymal stromal cell culture. Cytometry A 2018; 93(1): 60-72.
[59]
de Witte SFH, Luk F, Sierra Parraga JM, et al. Immunomodulation by therapeutic mesenchymal Stromal Cells (MSC) is triggered through phagocytosis of MSC by Monocytic Cells. Stem Cells 2018; 36(4): 602-15.
[60]
Kim JH, Kim N. Regulation of NFATc1 in Osteoclast Differentiation. J Bone Metab 2014; 21(4): 233-41.
[61]
Jackson MV, Krasnodembskaya AD. Analysis of mitochondrial transfer in direct co-cultures of human Monocyte-Derived Macrophages (MDM) and Mesenchymal Stem Cells (MSC). Bio Protoc 2017; 7(9): e2255.
[62]
Fan X, Guo D, Cheung AMS, et al. Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease. Biol Blood Marrow Transplant 2018; 24(10): 1971-80.
[63]
Ghiasvand S, Bakhshinejad B, Mowla SJ, Sadeghizadeh M. Potential roles of 5 UTR and 3 UTR regions in post-trans-criptional regulation of mouse Oct4 gene in BMSC and P19 cells. Iran J Basic Med Sci 2014; 17(7): 490-6.
[64]
Li J, Xing F, Chen F, et al. Functional 3D human liver bud assembled from MSC-derived multiple liver cell lineages. Cell Transplant 2018; 963689718780332.
[65]
Xiong LL, Li Y, Shang FF, et al. Chondroitinase administration and pcDNA3.1-BDNF-BMSC transplantation promote motor functional recovery associated with NGF expression in spinal cord-transected rat. Spinal Cord 2016; 54(12): 1088-95.
[66]
Guan SP, Lam ATL, Newman JP, et al. Matrix metalloproteinase-1 facilitates MSC migration via cleavage of IGF-2/IGFBP2 complex. FEBS Open Bio 2018; 8(1): 15-26.
[67]
Zavala G, Prieto CP, Villanueva AA, Palma V. Sonic hedgehog (SHH) signaling improves the angiogenic potential of Wharton’s jelly-derived mesenchymal stem cells (WJ-MSC). Stem Cell Res Ther 2017; 8(1): 203.